PREVIEW · SAMPLE DATA
This is the AGMB dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for AGMB.

AGMB

AgomAb Therapeutics NV
Healthcare · Biotechnology
$174.26 sample
+2.67 (+1.56%) 1D
☆ Watch
Market cap
$912.2B
Price as of
2026-10-24
Latest filing
8-K · 2026-10-21
Alerts
8
Price$174.26 +2.40% 3M daily closessample
182.88168.47
2026-07-282026-08-192026-09-102026-10-012026-10-23
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 21SECDEF 14A filed
  • Oct 16SEC8-K filed: material event
  • Oct 13INSInsider sell: EVP, Operations
  • Oct 07INSInsider buy: Director
  • Sep 28INSInsider sell: General Counsel
  • Sep 18INSInsider sell: General Counsel
  • Sep 15SEC8-K filed: material event
  • Sep 04INSInsider sell: EVP, Operations
Sign up to see the real AGMB record →

Company facts

SEC EDGAR registration
Name
AgomAb Therapeutics NV
Sector
Healthcare
Industry
Biotechnology
Smart-money score
+57sample, -100 to +100
Reporting currency
USD

Who is positioning in AGMB

sample
Insiders
24 insider transactions over 90 days, net selling, $819.6M
Congress
No member trades over 90 days
Institutions · 13F
17 funds hold $19.9B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$39.5B +18.6% y/y
Q4 2024Q3 2026
Inventory$23.9B +9.0% y/y
Q4 2024Q3 2026
Accounts receivable$18.1B +15.8% y/y
Q4 2024Q3 2026
Total debt$46.9B +12.5% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$105.4B -4.9% 3M
Sample peer B
$317.6B -11.7% 3M
Sample peer C
$656.3B +13.2% 3M
Sample peer D
$638.3B +14.4% 3M
Sample peer E
$651.6B -6.3% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not AGMB's real figure. Nothing here is investment advice.